Chuikyo OKs 7 Drugs Subject to Cost-Effective Review; Re-Pricing to Be Conducted in 2018

Healthcare Provider Reps at Chuikyo General Assembly A powerful health ministry panel on April 27 agreed to subject seven drugs including Sovaldi (sofosbuvir) and Opdivo (nivolumab) to a pilot-based cost effective assessment scheme, with a plan to carry out re-pricing...read more